South Korean Biotech Firm Secures $183.3M to Fuel Bold Bitcoin Treasury Strategy
Move over, traditional reserves—this biotech player is betting big on crypto.
In a move that blurs the lines between biotech and blockchain, a South Korean firm just raised $183.3 million with one audacious goal: building a Bitcoin war chest. Because nothing says 'long-term growth strategy' like volatile digital assets, right?
The funding round—likely making venture capitalists sweat—signals a growing trend of corporations diversifying into crypto. No gold bars or Treasury bonds here. Just pure, unfiltered Satoshi vision.
While Wall Street hedges with ETFs, this company's going straight to the source. Will their balance sheet moon or crater? Only time—and Bitcoin's next 20% swing—will tell.